Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07209475) titled 'Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers' on Oct. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Royal Biologics
Condition:
Diabetic Foot Ulcer (DFU)
Amnio-Maxx
Intervention:
Biological: Amnio-Maxx(R) Dual Layer Amnion Patch
Recruitment Status: Recruiting
Phase: Phase 4
Date of First Enrollment: August 14, 2025
Target Sample Size: 248
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/NCT07209475...